Affiliations 

  • 1 Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India
  • 2 Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia
  • 3 School of Pharmacy and Pharmaceutical Sciences, Ulster University, Londonderry, United Kingdom
  • 4 Department of Pharmaceutical Sciences, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan
  • 5 Department of Chemistry, University of Petroleum and Energy Studies, Dehradun, India
  • 6 School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, India
  • 7 Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences and National Health Laboratory Service, University of the Free State, Bloemfontein, South Africa
  • 8 Department of Life Sciences, School of Basic Science and Research, Sharda University, Greater Noida, India
  • 9 Department of Biotechnology, School of Engineering and Technology (SET), Sharda University, Greater Noida, India
  • 10 School of Pharmaceutical Sciences, Suresh Gyan Vihar University, Jaipur, India
  • 11 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia
Assay Drug Dev Technol, 2021 05 14;19(4):246-261.
PMID: 33989048 DOI: 10.1089/adt.2021.012

Abstract

Nanoemulsions (NMs) are one of the most important colloidal dispersion systems that are primarily used to improve the solubility of poorly water soluble drugs. The main objectives of this study were, first, to prepare an NM loaded with fenofibrate using a high shear homogenization technique and, second, to study the effect of variable using a central composite design. Twenty batches of fenofibrate-loaded NM formulations were prepared. The formed NMs were subjected to droplet size analysis, zeta potential, entrapment efficiency, pH, dilution, polydispersity index, transmission electron microscopy (TEM), Fourier transform infrared spectrophotometry, differential scanning calorimetry (DSC), and in vitro drug release study. Analysis of variance was used for entrapment efficiency data to study the fitness and significance of the design. The NM-7 batch formulation demonstrated maximum entrapment efficiency (81.82%) with lowest droplet size (72.28 nm), and was thus chosen as the optimized batch. TEM analysis revealed that the NM was well dispersed with droplet sizes <100 nm. Incorporation of the drug into the NM was confirmed with DSC studies. In addition, the batch NM-7 also showed the maximum in vitro drug release (87.6%) in a 0.05 M sodium lauryl sulfate solution. The release data revealed that the NM followed first-order kinetics. The outcomes of the study revealed the development of a stable oral NM containing fenofibrate using the high shear homogenization technique. This approach may aid in further enhancing the oral bioavailability of fenofibrate, which requires further in vivo studies.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.